ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

DAVI vs LNSR // RSI-14 & 200D SMA MOMENTUM

Davion Healthcare Plc (NASDAQ) VS. LENSAR Inc. (NASDAQ) • 15-METRIC TALLY: DAVI 0 — LNSR 2
▲ RSI-14 & 200D SMA MOMENTUM LEADER: LNSR
rsi-technicals
34.6
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (DAVI VS. LNSR) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC DAVI LNSR SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — 39.40% — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) — -35.00% — TIE /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield — -20.33% — TIE /fcf-yield <GO>
Operating Margin — -47.60% — TIE /operating-margins <GO>
Net Profit Margin — -60.00% — TIE /net-margins <GO>
Revenue Growth (YoY) — 12.40% — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — 0.20 — TIE /balance-sheet <GO>
Piotroski F-Score Quality — 4/9 — TIE /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum ACTIVE 18.0 34.6 -16.57 LNSR /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $67.3M $73.3M -$6.1M LNSR /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR DAVI REV LNSR REV DAVI GROSS % LNSR GROSS % DAVI FCF LNSR FCF
FY 2025 — $51.7M — 39.4% — -$14.9M
FY 2024 — $46.0M — 39.9% — -$2.4M
FY 2023 — $35.7M — — — -$9.7M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
DAVI // BETA —
LNSR // BETA —